Global DNA Sequencing & Next-Generation Sequencing Market, By Product Type (Instruments, Consumables, Services), Application (Research, Diagnostic, Drug Discovery, Clinical, Agriculture & Animal Research), Type (Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing), Technology (Sequencing By Synthesis, Nanopore Sequencing, Sequencing By Ligation (SBL), Ion Semiconductor Sequencing, Pyrosequencing, Chain Termination Sequencing, Single-Molecule Real-Time Sequencing (SMRT), and Others), Platform (Sanger, Next Generation Sequencing, qPCR and Others), End-user (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
Market Analysis and Insights: Global DNA Sequencing and Next-Generation Sequencing Market
DNA sequencing & next-generation sequencing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 9,193.38 million by 2027 from USD 2,923.00 million growing at a CAGR of 15.40% in the above-mentioned forecast period. The cost-effectiveness and present conversion parameters, though effective to generate quality outcomes in the genome medicines are influencing the market, this increment is supported up the investment for analysis and progress of RNA and DNA investigations are aiding the business to increase exponentially through the foreseen period.
The industry is anticipated to succeed at a great speed owing to individual determinants such as the burgeoning demand for pharmacogenomics in dose expansion and progression, decreasing prices of sequencing, technological improvements, and the increasing necessity for economical genotyping assistance. Some of the additional constituents propelling the business increase are increasing incidence and knowledge of generative ailments and personalized medication, among the useful purpose of hereditary analysis on vertebrates and mills, specific parts are pushing the business increase. The business is exposed to some of the constraining determinants such as operations on rodents and animals which is against the moral standards, the dearth of qualified experts or may say the business can serve as a constraint for the business increase. To sustain the industry growth possible prospects of achieving a remedy for the oncology and resuming designs by the biotech firms will assist in working above asserted weaknesses of the market.
This DNA sequencing & next-generation sequencing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research DNA sequencing & next-generation sequencing market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global DNA Sequencing & Next-Generation Sequencing Market Scope and Market Size
DNA sequencing & next-generation sequencing market is segmented on the basis of product type, application, type, technology, platform and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the DNA sequencing & next-generation sequencing market is segmented into instruments, consumables, and services.
- On the basis of application, the DNA sequencing & next-generation sequencing market is segmented into research, diagnostic, drug discovery, clinical, agriculture & animal research.
- On the basis of type, the DNA sequencing & next-generation sequencing market is segmented into whole genome sequencing, exome sequencing, targeted sequencing.
- On the basis of technology, the DNA sequencing & next-generation sequencing market is segmented into sequencing by synthesis, nanopore sequencing, sequencing by ligation (SBL), ion semiconductor sequencing, pyrosequencing, chain termination sequencing, single-molecule real-time sequencing (SMRT), and others.
- On the basis of platform, the DNA sequencing & next-generation sequencing market is segmented into sanger, next generation sequencing, qPCR and others.
- On the basis of end user, the DNA sequencing & next-generation sequencing market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies.
DNA Sequencing & Next-Generation Sequencing Market Country Level Analysis
DNA sequencing & next-generation sequencing market is analysed and market size insights and trends are provided by country, product type, application, type, technology, platform and end user as referenced above.
The countries covered in the DNA sequencing & next-generation sequencing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific (APAC) governs the business. China is prophesied to witness distinguished germination in the projection years owing to an augmentation in analysis and advancement investment and a surge in the use of sequencing. Furthermore, the Chinese province extends exceptional opportunities for market investors and businesspeople, as the developed nations are nearly overfilled.
The country section of the DNA sequencing & next-generation sequencing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
DNA sequencing & next-generation sequencing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for DNA sequencing & next-generation sequencing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the DNA sequencing & next-generation sequencing market. The data is available for historic period 2010 to 2018.
Competitive Landscape and DNA sequencing & next-generation sequencing market Share Analysis
DNA sequencing & next-generation sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to DNA sequencing & next-generation sequencing market.
The major players covered in the DNA sequencing & next-generation sequencing market report are Thermo Fisher Scientific, Illumina, Inc., QIAGEN, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., BGI, Danaher., GENERAL ELECTRIC COMPANY, Eppendorf AG, Abbott, LI-COR, Inc., Siemens, PerkinElmer Inc., Macrogen Inc., DNASTAR, Geneious, Myriad Genetics, Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available: Global DNA Sequencing and Next-Generation Sequencing Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.